by admin | May 29, 2024 | Investment News
Attomarker has been selected as one of the companies by Innovate UK for the following category: GBIP in Hyderabad and Bangalore, India – Antimicrobial Resistance, diagnostics and therapeutics Why India? India has recognised the importance of AMR, and the Indian...
by admin | Nov 29, 2023 | Investment News
We are working with partners to enable early medical intervention for longer, healthier lives for humans and animals. Attomarker Ltd is offering an Advanced Subscription Agreement funding round to support product development, regulatory and roll out. A full set...
by admin | Jul 27, 2022 | Customer Stories & Cases
Attomarker has partnered with Integra Healthcare in the Cayman Islands, where only 31% of the population has received a boosterdose. The medical team introduced the test to the community with a VIP launch and an informative in-depth article in the Cayman Compass,...
by admin | Jul 27, 2022 | Science
Attomarker technology is a label-free particle plasmon resonance multiplexed array that can measure the concentration quantitatively for up to 20 species in 10 µL blood sample in 7 minutes. The original idea came from a proposal to the Engineering and Physical...
by admin | Jul 27, 2022 | Science
The Attomarker Antibody Immunity Test measures antibodies in the blood to the SARS-CoV-2 coronavirus causing COVID-19. The total IgG response is measured to three antigens on the surface of the virus: Nucleocapsid (N), Spike (S) (and now Omicron Spike) and...
